肝移植受者新型冠状病毒感染的防护

Prevention of novel coronavirus infection in liver transplant recipients

2019年12月我国武汉市出现的新型冠状病毒肺炎(COVID-19)是一种急性呼吸道传染病,可在人与人之间相互传播。该新型冠状病毒感染导致的肺炎患者数量快速增长,疫情已经蔓延至全国,全球多个国家亦陆续发现该COVID-19患者。而免疫力低下者更易患病,且更易进展为重症患者。肝移植受者长期使用免疫抑制药物,属于免疫力低下人群,因此,此类人群尤其应该加强防护。本文就COVID-19的认识、传播机制及肝移植受者防护措施作一综述,旨在降低肝移植受者感染新型冠状病毒的风险。

In December of 2019,the novel coronavirus pneumonia(COVID-19)in Wuhan is an acute respiratory infectious disease,which can spread from person to person.The number of pneumonia patients caused by the novel coronavirus has increased rapidly,and the epidemic situation has spread to the whole country.The COVID-19 patients have also been found in many countries around the world.People with low immunity are more likely to get sick and develop into severe patients.Liver transplant recipients belong to low immunity people for using of immunosuppressive drugs chronically.Therefore,liver transplant recipients should especially strengthen their protection from virus.This article reviews the understanding,transmission mechanism of COVID-19 and protective measures for liver transplant recipients,aiming at reducing the risk of infection with new coronavirus in liver transplant recipients.